Inspire Medical Systems (INSP) Total Liabilities (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Total Liabilities data on file, last reported at $119.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 25.21% year-over-year to $119.0 million; the trailing twelve-month figure through Mar 2026 stood at $119.0 million (up 25.21% YoY), and the FY2025 full-year result was $126.2 million, up 6.29% from the prior year.
• Total Liabilities declined to $119.0 million in Q1 2026, from $126.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $141.3 million in Q3 2025 to a low of $57.3 million in Q3 2022.
• A 5-year average of $95.5 million and a median of $95.3 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities retreated 2.18% in 2022 and surged 66.29% in 2023, its largest moves.
• Tracing INSP's Total Liabilities over 5 years: stood at $68.9 million in 2022, then soared by 51.44% to $104.3 million in 2023, then increased by 13.8% to $118.7 million in 2024, then gained by 6.29% to $126.2 million in 2025, then fell by 5.64% to $119.0 million in 2026.
• Business Quant data shows INSP's Total Liabilities at $119.0 million in Q1 2026, $126.2 million in Q4 2025, and $141.3 million in Q3 2025.